<div id="readability-page-1"><p>Douglas Lane &amp; Associates LLC decreased its position in  UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 9.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 77,271 shares of the healthcare conglomerate's stock after selling 8,458 shares during the period. Douglas Lane &amp; Associates LLC's holdings in UnitedHealth Group were worth $24,106,000 as of its most recent SEC filing.</p><div><p><span></span><span>Get <strong>UnitedHealth Group</strong> alerts:</span></p></div><ul><li>More Than a Rebound: UnitedHealth Is Back in the Game</li></ul><p>Other hedge funds have also made changes to their positions in the company. Bayforest Capital Ltd grew its stake in shares of  UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after buying an additional 48 shares during the period.  Clal Insurance Enterprises Holdings Ltd grew its stake in shares of  UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after buying an additional 50 shares during the period.  IAG Wealth Partners LLC purchased a new position in shares of  UnitedHealth Group during the 1st quarter worth approximately $42,000.  Copia Wealth Management purchased a new position in shares of  UnitedHealth Group during the 4th quarter worth approximately $42,000.  Finally, O Brien Wealth Partners LLC boosted its position in shares of  UnitedHealth Group by 74.0% during the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock worth $46,000 after purchasing an additional 37 shares during the period. Hedge funds and other institutional investors own  87.86% of the company's stock. </p><h2>Analyst Ratings Changes</h2><p>A number of research firms recently weighed in on UNH. Truist Financial increased their price objective on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a &#34;buy&#34; rating in a research report on Tuesday, September 9th. TD Cowen cut shares of UnitedHealth Group from a &#34;buy&#34; rating to a &#34;hold&#34; rating and set a $308.00 price target for the company. in a research report on Monday, May 19th. Sanford C. Bernstein raised their price target on shares of UnitedHealth Group from $337.00 to $379.00 and gave the company an &#34;outperform&#34; rating in a research report on Friday, September 5th. Morgan Stanley raised their price target on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an &#34;overweight&#34; rating in a research report on Friday. Finally, Wolfe Research decreased their price target on shares of UnitedHealth Group from $501.00 to $390.00 and set an &#34;outperform&#34; rating for the company in a research report on Tuesday, May 20th. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned  a Hold rating and three have issued  a Sell rating to the stock. According to data from MarketBeat, UnitedHealth Group  has an average rating of &#34;Moderate Buy&#34; and an average price target of $358.95.</p><ul><li>As the Market Rotates, This Healthcare ETF Is Leading the Way</li></ul><p><b>View Our Latest Research Report on UNH</b></p><h2>UnitedHealth Group Price Performance</h2><p>Shares of UNH opened at $352.61 on Friday. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The firm's fifty day simple moving average is $291.98 and its 200-day simple moving average is $369.01. The firm has a market capitalization of $319.35 billion, a price-to-earnings ratio of 15.28, a PEG ratio of 2.31 and a beta of 0.45. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. </p><ul><li>Top 5 ETFs and Stocks to Watch as the Fed Eyes Rate Cuts</li></ul><p>UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.UnitedHealth Group's revenue was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.80 earnings per share.  UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities analysts forecast that  UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year. </p><h2>UnitedHealth Group Announces Dividend</h2><p>The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group's dividend payout ratio (DPR) is presently 38.30%. </p><h2>About UnitedHealth Group</h2> (Free Report)<p>UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than UnitedHealth Group</li><li>ESG Stocks, What Investors Should Know</li><li>Ride the Luxury Retail Wave with These 3 High-End Brand Stocks</li><li>What Makes a Stock a Good Dividend Stock?</li><li>Wall Street Quietly Bets Big on These Chinese Tech Giants</li><li>What Are the U.K. Market Holidays? How to Invest and Trade</li><li>Meta's $600B U.S. Investment: Bearish or Bullish for Shares? </li></ul><p><strong>Want to see what other hedge funds are holding UNH?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in UnitedHealth Group Right Now?</h2><p>Before you consider UnitedHealth Group, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.</p><p>While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Douglas Lane & Associates LLC reduced its stake in UnitedHealth Group (NYSE:UNH) by 9.9% in Q2, now holding 77,271 shares valued at $24.1 million. Other hedge funds have increased their positions significantly. Analysts have mixed ratings on UNH, with a consensus rating of "Moderate Buy" and an average price target of $358.95. UNH shares opened at $352.61, with a 12-month range of $234.60 to $630.73. The company reported Q2 earnings of $4.08 EPS, missing estimates, with revenue of $111.62 billion, up 12.9% year-over-year.</p>

UnitedHealth Group Incorporated $UNH Shares Sold by Douglas Lane & Associates LLC